Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer′s disease: Findings of an observational study | Zendy

Suyog Mehta | Zendy; K Chandersekhar | Zendy; G Prasadrao | Zendy; Lakshman Dutt | Zendy; Shraddha Patkar | Zendy; RD Nagpal | Zendy; Monica Gupta | Zendy; G. Suryanarayana Raju | Zendy; KK Praveen | Zendy; B S Prasad | Zendy; T Roy | Zendy; Suman Kushwaha | Zendy; Jyotindra Nag | Zendy; Deepak Langade | Zendy; D. Pawar | Zendy

Open Access

Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer′s disease: Findings of an observational study

Author(s) -

Suyog Mehta,

K Chandersekhar,

G Prasadrao,

Lakshman Dutt,

Shraddha Patkar,

RD Nagpal,

Monica Gupta,

G. Suryanarayana Raju,

KK Praveen,

B S Prasad,

T Roy,

Suman Kushwaha,

Jyotindra Nag,

Deepak Langade,

D. Pawar

Publication year - 2012

Publication title -

indian journal of psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.485

H-Index - 34

eISSN - 1998-3794

pISSN - 0019-5545

DOI - 10.4103/0019-5545.104820

Subject(s) - donepezil , dementia , medicine , adverse effect , acetylcholinesterase , rating scale , clinical dementia rating , cholinesterase , dose , activities of daily living , observational study , disease , psychology , physical therapy , developmental psychology , biochemistry , chemistry , enzyme

Alzheimer's disease (AD), a progressive brain disorder, is the most common cause of dementia among the elderly. Donepezil hydrochloride is a potent, reversible, and highly selective inhibitor of acetylcholinesterase (AChE). It is chemically distinct from other cholinesterase (ChE) inhibitors which are effective in the treatment of AD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research